Home » Topics » Regulatory

Regulatory
RSS

FDA approval for Xalatan as first-line therapy for elevated IOP

Jan. 2, 2003

Shire seeks approval of Adderall XR in adults

Dec. 23, 2002

Kytril available in oral solution for CINV and RINV

Dec. 23, 2002

Moxifloxacin NDA filed for bacterial conjunctivitis and ophthalmia neonatorum

Dec. 20, 2002

E.U. approval obtained for use of Enbrel in psoriatic arthritis

Dec. 20, 2002

Lantus: E.U. approval for flexible use, positive opinion for pediatric use

Dec. 19, 2002

Approvable letter for Advair Diskus

Dec. 19, 2002

Extended-release Cipro cleared for uncomplicated urinary tract infections

Dec. 18, 2002

Data supporting use of Risperdal for bipolar disorder submitted to FDA

Dec. 17, 2002

Lilly seeks expanded indication for Gemzar in Europe

Dec. 17, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 9, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Medline plans record-setting $5.37B IPO
BioWorld MedTech
Almost a year since first filing its S-1 to return to public markets, Medline Inc. revealed the price range for the most awaited IPO of 2025. The massive medical...